Browse studies

Find your next paid study

91 recruiting studies matching your filters

Randomized, Double-blind, Placebo-controlled Proof-of-Concept (PoC) Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

This is a 2-Part study with Part A, a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod…

Interstitial Lung Disease

Estimated

~$75 – $2,800

Actual pay is set by the research site.

aTyr Pharma, Inc.NCT05892614

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmo…

Pulmonary HypertensionInterstitial Lung DiseaseVascular Diseases+2 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Pulmovant, Inc.NCT07816185

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

Background: Lung transplants can save lives, but the procedure has risks. Some people develop donor-specific antibodies (DSA) after the procedure-that is, the…

Lung TransplantEnd Stage Lung DiseaseRejection

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT07516379

University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Interstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary Fibrosis+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Kansas Medical CenterNCT05392881

Phase 2

A Phase II Study of BIO 300 to Reduce the Toxicity of Thoracic Radiotherapy for Patients With Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease (BREATHE)

The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people wi…

NSCLCNSCLC, Stage INSCLC Stage II+5 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07323732

Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

The purpose of this study is to determine if sequence variations in genes involved in the development and function of vulnerable organs increases susceptibilit…

Chronic Lung Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical College of WisconsinNCT00710112

Observational

Addressing Symptoms With Person-Centered Treatment (ADAPT) (QUE 25-018)

Many Veterans living with heart failure or chronic obstructive pulmonary disease (COPD) experience significant symptoms - such as breathlessness, fatigue, depr…

Heart FailurePulmonary Disease, Chronic ObstructiveInterstitial Lung Disease

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07714252

Phase 2

Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)

The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with oth…

Systemic SclerosisDiffuse Sclerosis SystemicInterstitial Lung Disease+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Paul SzabolcsNCT03630211

Observational

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hos…

DiabetesHypertensionHigh Cholesterol/Hyperlipidemia+10 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of TennesseeNCT06374277

Observational

MOBoxy: MoblO2 to Maintain Oxygenation

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2…

COPD (Chronic Obstructive Pulmonary Disease)Intersitital Lung Disease

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Minnesota HealthSolutionsNCT07704567

Phase 2

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to i…

Interstitial Lung DiseaseChronic Thromboembolic Pulmonary HypertensionAcute Pulmonary Embolism+3 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Bastiaan DriehuysNCT06038630

Phase 2

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis

RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis

Systemic SclerosisSclerodermaInterstitial Lung Diseases

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Cabaletta BioNCT06328777